2d6e238ddde8247d8aa749467999543a  Teclistamab_Improves_Patient-Reported.pdf
b74b1ab0486f833ffa2189898bce9a884ff38c87  Teclistamab_Improves_Patient-Reported.pdf
8cce80d2e48467cf648d57c534b4c08520958fd458b3ded7368df18a73ca8434  Teclistamab_Improves_Patient-Reported.pdf

Title:          Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study
Subject:        Clinical Lymphoma, Myeloma and Leukemia, 24 (2024) 194-202. doi:10.1016/j.clml.2023.11.001
Keywords:       "B-cell maturation antigen"; "Bispecific antibody"; "EORTC QLQ-C30"; "EQ-5D-5L"; "Patient-reported outcomes"
Author:         Thomas G. Martin
Creator:        Elsevier
Producer:       Acrobat Distiller 10.0.0 (Windows)
CreationDate:   Thu Feb 15 09:52:27 2024 CET
ModDate:        Thu Feb 15 09:52:45 2024 CET
Tagged:         yes
UserProperties: no
Suspects:       no
Form:           none
JavaScript:     no
Pages:          9
Encrypted:      no
Page size:      594 x 783 pts
Page rot:       0
File size:      617745 bytes
Optimized:      yes
PDF version:    1.7


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
JBAMGE+FuturaStd-Condensed           Type 1C           Custom           yes yes yes    824  0
JBAMCE+MTSY                          Type 1C           Custom           yes yes yes    829  0
JBAMBC+HelveticaLTStd-Bold           Type 1C           Custom           yes yes yes    834  0
JBAMCD+HelveticaLTStd-Roman          Type 1C           Custom           yes yes yes    839  0
JBALGE+HelveticaNeueLTStd-BdEx       Type 1C           Custom           yes yes yes    844  0
JBALOD+AGaramond-Regular             Type 1C           Custom           yes yes no     849  0
JBAMGD+Futura-DemiBold               Type 1C           Custom           yes yes yes    853  0
JBAMGF+FuturaStd-CondensedLight      Type 1C           Custom           yes yes yes    858  0
JBALGF+dummy-space                   Type 1C           WinAnsi          yes yes no     863  0
JBAMHI+HelveticaLTStd-Light          Type 1C           Custom           yes yes yes      3  0
JBAMHH+HelveticaLTStd-Obl            Type 1C           Custom           yes yes yes      8  0
JBAMHG+AGaramond-BoldItalic          Type 1C           WinAnsi          yes yes no     133  0
JBAMOG+FuturaStd-CondensedBold       Type 1C           Custom           yes yes yes    136  0
JBAMPH+AGaramond-Bold                Type 1C           WinAnsi          yes yes no     157  0
JBANAH+AGaramond-Italic              Type 1C           WinAnsi          yes yes no     160  0
JBANFG+HelveticaLTStd-BoldCond       Type 1C           Custom           yes yes yes    163  0
JBANHI+MTSYB                         Type 1C           Custom           yes yes yes    168  0
JBANGH+HelveticaLTStd-LightCond      Type 1C           Custom           yes yes yes     50  0
JBAOLB+RMTMI                         Type 1C           Custom           yes yes yes    173  0
JBBAAJ+TimesNewRomanPSMT-20          Type 1C           Custom           yes yes yes     85  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2024-02-28 02:34:58 CET
 RepresentationInformation: Teclistamab_Improves_Patient-Reported.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2024-02-27 15:43:27 CET
  Size: 617745
  Format: PDF
  Version: 1.7
  Status: Well-Formed, but not valid
  SignatureMatches:
   PDF-hul
  ErrorMessage: Invalid indirect destination - referenced object 'tb1fn3' cannot be found
   ID: PDF-HUL-149
  ErrorMessage: Invalid indirect destination - referenced object 'tb1fn1' cannot be found
   ID: PDF-HUL-149
  ErrorMessage: Invalid indirect destination - referenced object 'tb1fn5' cannot be found
   ID: PDF-HUL-149
  ErrorMessage: Invalid indirect destination - referenced object 'tb1fn2' cannot be found
   ID: PDF-HUL-149
  ErrorMessage: Invalid indirect destination - referenced object 'tb1fn4' cannot be found
   ID: PDF-HUL-149
  ErrorMessage: edu.harvard.hul.ois.jhove.module.pdf.PdfInvalidException: Invalid indirect destination - referenced object 'tb1fn1' cannot be found
   ID: PDF-HUL-122
   Offset: 547316
  ErrorMessage: edu.harvard.hul.ois.jhove.module.pdf.PdfInvalidException: Invalid indirect destination - referenced object 'tb1fn3' cannot be found
   ID: PDF-HUL-122
   Offset: 547316
  ErrorMessage: edu.harvard.hul.ois.jhove.module.pdf.PdfInvalidException: Invalid indirect destination - referenced object 'tb1fn4' cannot be found
   ID: PDF-HUL-122
   Offset: 547316
  ErrorMessage: edu.harvard.hul.ois.jhove.module.pdf.PdfInvalidException: Invalid indirect destination - referenced object 'tb1fn5' cannot be found
   ID: PDF-HUL-122
   Offset: 547316
  ErrorMessage: edu.harvard.hul.ois.jhove.module.pdf.PdfInvalidException: Invalid indirect destination - referenced object 'tb1fn2' cannot be found
   ID: PDF-HUL-122
   Offset: 547316
  MIMEtype: application/pdf
  Profile: Linearized PDF, Tagged PDF
  PDFMetadata: 
   Objects: 917
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    ViewerPreferences: 
     HideToolbar: false
     HideMenubar: false
     HideWindowUI: false
     FitWindow: false
     CenterWindow: false
     DisplayDocTitle: true
     NonFullScreenPageMode: UseNone
     Direction: L2R
     ViewArea: CropBox
     ViewClip: CropBox
     PrintArea: CropBox
     PageClip: CropBox
    PageLayout: SinglePage
    PageMode: UseOutlines
    Language: English
    Outlines: 
     Item: 
      Title: Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study
      Destination: chapter..1
      Children: 
       Item: 
        Title: Introduction
        Destination: section..1
       Item: 
        Title: Patients and Methods
        Destination: section..2
        Children: 
         Item: 
          Title: Study Design and Patients
          Destination: subsection..2.1
         Item: 
          Title: Assessment of Patient-Reported Outcomes
          Destination: subsection..2.2
         Item: 
          Title: Statistical Analyses
          Destination: subsection..2.3
       Item: 
        Title: Results
        Destination: section..3
        Children: 
         Item: 
          Title: Patient Characteristics and Compliance With PROs
          Destination: subsection..3.1
         Item: 
          Title: Change in PROs During Treatment
          Destination: subsection..3.2
         Item: 
          Title: Proportion of Patients With Meaningful Changes From Baseline
          Destination: subsection..3.3
       Item: 
        Title: Discussion
        Destination: section..4
       Item: 
        Title: Conclusions
        Destination: section..5
        Children: 
         Item: 
          Title: Clinical Practice Points
          Destination: subsection..5.1
       Item: 
        Title: Ethics Statement
        Destination: section..6
       Item: 
        Title: Patient Consent
        Destination: section..7
       Item: 
        Title: Permission to Reproduce Material From Other Sources
        Destination: section..8
       Item: 
        Title: Clinical Trial Registration
        Destination: section..9
       Item: 
        Title: Data Availability Statement
        Destination: section..10
       Item: 
        Title: Disclosure
        Destination: section..11
       Item: 
        Title: Acknowledgments
        Destination: section..12
       Item: 
        Title: Supplementary materials
        Destination: section..13
       Item: 
        Title: References
        Destination: section..14
   Info: 
    Title: Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study
    Author: Thomas G. Martin
    Subject: Clinical Lymphoma, Myeloma and Leukemia, 24 (2024) 194-202. doi:10.1016/j.clml.2023.11.001
    Keywords: "B-cell maturation antigen"; "Bispecific antibody"; "EORTC QLQ-C30"; "EQ-5D-5L"; "Patient-reported outcomes"
    Creator: Elsevier
    Producer: Acrobat Distiller 10.0.0 (Windows)
    CreationDate: Thu Feb 15 10:22:27 CET 2024
    ModDate: Thu Feb 15 10:22:45 CET 2024
   ID: 0xa504bbe9f8855cf1a1c5549542ee4d58, 0x7d875ac1b9c4db75ffe21ece9305316c
   Filters: 
    FilterPipeline: FlateDecode
   Fonts: 
    Type1: 
     Font: 
      BaseFont: JBANAH+AGaramond-Italic
      FontSubset: true
      FirstChar: 40
      LastChar: 121
      FontDescriptor: 
       FontName: JBANAH+AGaramond-Italic
       Flags: Serif, Nonsymbolic, Italic
       FontBBox: -182, -285, 1150, 851
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: JBAMBC+HelveticaLTStd-Bold
      FontSubset: true
      FirstChar: 40
      LastChar: 147
      FontDescriptor: 
       FontName: JBAMBC+HelveticaLTStd-Bold
       Flags: Symbolic, ForceBold
       FontBBox: -170, -228, 1003, 962
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAMHI+HelveticaLTStd-Light
      FontSubset: true
      FirstChar: 40
      LastChar: 169
      FontDescriptor: 
       FontName: JBAMHI+HelveticaLTStd-Light
       Flags: Symbolic
       FontBBox: -164, -250, 1000, 979
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBANFG+HelveticaLTStd-BoldCond
      FontSubset: true
      FirstChar: 2
      LastChar: 121
      FontDescriptor: 
       FontName: JBANFG+HelveticaLTStd-BoldCond
       Flags: Symbolic, ForceBold
       FontBBox: -169, -250, 1091, 991
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAMHG+AGaramond-BoldItalic
      FontSubset: true
      FirstChar: 45
      LastChar: 121
      FontDescriptor: 
       FontName: JBAMHG+AGaramond-BoldItalic
       Flags: Serif, Nonsymbolic, Italic, ForceBold
       FontBBox: -183, -285, 1166, 862
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: JBAMCD+HelveticaLTStd-Roman
      FontSubset: true
      FirstChar: 37
      LastChar: 147
      FontDescriptor: 
       FontName: JBAMCD+HelveticaLTStd-Roman
       Flags: Symbolic
       FontBBox: -166, -225, 1000, 931
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAMHH+HelveticaLTStd-Obl
      FontSubset: true
      FirstChar: 44
      LastChar: 121
      FontDescriptor: 
       FontName: JBAMHH+HelveticaLTStd-Obl
       Flags: Symbolic, Italic
       FontBBox: -170, -225, 1116, 931
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAMOG+FuturaStd-CondensedBold
      FontSubset: true
      FirstChar: 48
      LastChar: 57
      FontDescriptor: 
       FontName: JBAMOG+FuturaStd-CondensedBold
       Flags: Symbolic, ForceBold
       FontBBox: -140, -261, 1195, 990
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBANHI+MTSYB
      FontSubset: true
      FirstChar: 2
      LastChar: 61
      FontDescriptor: 
       FontName: JBANHI+MTSYB
       Flags: Symbolic, ForceBold
       FontBBox: -16, -935, 1043, 896
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBALGE+HelveticaNeueLTStd-BdEx
      FontSubset: true
      FirstChar: 65
      LastChar: 121
      FontDescriptor: 
       FontName: JBALGE+HelveticaNeueLTStd-BdEx
       Flags: Symbolic, ForceBold
       FontBBox: -145, -213, 1163, 984
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAOLB+RMTMI
      FontSubset: true
      FirstChar: 60
      LastChar: 60
      FontDescriptor: 
       FontName: JBAOLB+RMTMI
       Flags: Symbolic, Italic
       FontBBox: 0, -213, 987, 680
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBALOD+AGaramond-Regular
      FontSubset: true
      FirstChar: 30
      LastChar: 250
      FontDescriptor: 
       FontName: JBALOD+AGaramond-Regular
       Flags: Serif, Nonsymbolic
       FontBBox: -183, -269, 1099, 851
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: JBANGH+HelveticaLTStd-LightCond
      FontSubset: true
      FirstChar: 37
      LastChar: 147
      FontDescriptor: 
       FontName: JBANGH+HelveticaLTStd-LightCond
       Flags: Symbolic
       FontBBox: -170, -250, 1000, 986
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAMGD+Futura-DemiBold
      FontSubset: true
      FirstChar: 49
      LastChar: 57
      FontDescriptor: 
       FontName: JBAMGD+Futura-DemiBold
       Flags: Symbolic
       FontBBox: -153, -250, 1139, 930
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBBAAJ+TimesNewRomanPSMT-20
      FontSubset: true
      FirstChar: 128
      LastChar: 128
      FontDescriptor: 
       FontName: JBBAAJ+TimesNewRomanPSMT-20
       Flags: Symbolic
       FontBBox: -210, -216, 1066, 865
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAMGE+FuturaStd-Condensed
      FontSubset: true
      FirstChar: 44
      LastChar: 121
      FontDescriptor: 
       FontName: JBAMGE+FuturaStd-Condensed
       Flags: Symbolic
       FontBBox: -157, -216, 894, 969
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAMGF+FuturaStd-CondensedLight
      FontSubset: true
      FirstChar: 36
      LastChar: 169
      FontDescriptor: 
       FontName: JBAMGF+FuturaStd-CondensedLight
       Flags: Symbolic
       FontBBox: -125, -221, 896, 961
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAMCE+MTSY
      FontSubset: true
      FirstChar: 2
      LastChar: 215
      FontDescriptor: 
       FontName: JBAMCE+MTSY
       Flags: Symbolic
       FontBBox: 0, -954, 1043, 796
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: JBAMPH+AGaramond-Bold
      FontSubset: true
      FirstChar: 45
      LastChar: 121
      FontDescriptor: 
       FontName: JBAMPH+AGaramond-Bold
       Flags: Serif, Nonsymbolic, ForceBold
       FontBBox: -158, -269, 1147, 862
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: JBALGF+dummy-space
      FontSubset: true
      FirstChar: 32
      LastChar: 32
      FontDescriptor: 
       FontName: JBALGF+dummy-space
       Flags: Nonsymbolic
       FontBBox: 0, 0, 0, 0
       FontFile3: true
      Encoding: WinAnsiEncoding
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="XMP Core 5.1.2">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:xmp="http://ns.adobe.com/xap/1.0/">
         <xmp:CreateDate>2024-02-15T14:22:27+05:30</xmp:CreateDate>
         <xmp:CreatorTool>Elsevier</xmp:CreatorTool>
         <xmp:ModifyDate>2024-02-15T14:22:45+05:30</xmp:ModifyDate>
         <xmp:MetadataDate>2024-02-15T14:22:45+05:30</xmp:MetadataDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Producer>Acrobat Distiller 10.0.0 (Windows)</pdf:Producer>
         <pdf:Keywords>"B-cell maturation antigen"; "Bispecific antibody"; "EORTC QLQ-C30"; "EQ-5D-5L"; "Patient-reported outcomes"</pdf:Keywords>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:identifier>doi:10.1016/j.clml.2023.11.001</dc:identifier>
         <dc:publisher>
            <rdf:Bag>
               <rdf:li>Elsevier Inc.</rdf:li>
            </rdf:Bag>
         </dc:publisher>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Clinical Lymphoma, Myeloma and Leukemia, 24 (2024) 194-202. doi:10.1016/j.clml.2023.11.001</rdf:li>
            </rdf:Alt>
         </dc:description>
         <dc:subject>
            <rdf:Bag>
               <rdf:li>B-cell maturation antigen</rdf:li>
               <rdf:li>Bispecific antibody</rdf:li>
               <rdf:li>EORTC QLQ-C30</rdf:li>
               <rdf:li>EQ-5D-5L</rdf:li>
               <rdf:li>Patient-reported outcomes</rdf:li>
            </rdf:Bag>
         </dc:subject>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>Thomas G. Martin</rdf:li>
               <rdf:li>Philippe Moreau</rdf:li>
               <rdf:li>Saad Z. Usmani</rdf:li>
               <rdf:li>Alfred Garfall</rdf:li>
               <rdf:li>María-Victoria Mateos</rdf:li>
               <rdf:li>Jesús F. San-Miguel</rdf:li>
               <rdf:li>Albert Oriol</rdf:li>
               <rdf:li>Ajay K. Nooka</rdf:li>
               <rdf:li>Laura Rosinol</rdf:li>
               <rdf:li>Ajai Chari</rdf:li>
               <rdf:li>Lionel Karlin</rdf:li>
               <rdf:li>Amrita Krishnan</rdf:li>
               <rdf:li>Nizar Bahlis</rdf:li>
               <rdf:li>Rakesh Popat</rdf:li>
               <rdf:li>Britta Besemer</rdf:li>
               <rdf:li>Joaquín Martínez-López</rdf:li>
               <rdf:li>Michel Delforge</rdf:li>
               <rdf:li>Danielle Trancucci</rdf:li>
               <rdf:li>Lixia Pei</rdf:li>
               <rdf:li>Rachel Kobos</rdf:li>
               <rdf:li>John Fastenau</rdf:li>
               <rdf:li>Katharine S. Gries</rdf:li>
               <rdf:li>Niels W.C.J. van de Donk</rdf:li>
            </rdf:Seq>
         </dc:creator>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/">
         <xmpMM:DocumentID>uuid:fd8cfc10-4791-4a8b-8025-00abb91efa0c</xmpMM:DocumentID>
         <xmpMM:InstanceID>uuid:5c776359-1fcd-4ca1-9977-61a149ad1e91</xmpMM:InstanceID>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:prism="http://prismstandard.org/namespaces/basic/3.0/">
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:copyright>© 2024 The Authors. Published by Elsevier Inc.</prism:copyright>
         <prism:publicationName>Clinical Lymphoma, Myeloma and Leukemia</prism:publicationName>
         <prism:issn>2152-2650</prism:issn>
         <prism:volume>24</prism:volume>
         <prism:number>3</prism:number>
         <prism:doi>10.1016/j.clml.2023.11.001</prism:doi>
         <prism:url>https://doi.org/10.1016/j.clml.2023.11.001</prism:url>
         <prism:startingPage>194</prism:startingPage>
         <prism:endingPage>202</prism:endingPage>
         <prism:pageRange>194-202</prism:pageRange>
         <prism:coverDisplayDate>March 2024</prism:coverDisplayDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/">
         <pdfx:ElsevierWebPDFSpecifications>7.0</pdfx:ElsevierWebPDFSpecifications>
         <pdfx:CrossmarkMajorVersionDate>2010-04-23</pdfx:CrossmarkMajorVersionDate>
         <pdfx:CrossmarkDomainExclusive>true</pdfx:CrossmarkDomainExclusive>
         <pdfx:doi>10.1016/j.clml.2023.11.001</pdfx:doi>
         <pdfx:robots>noindex</pdfx:robots>
         <pdfx:AuthoritativeDomain>
            <rdf:Bag>
               <rdf:li>sciencedirect.com</rdf:li>
               <rdf:li>elsevier.com</rdf:li>
            </rdf:Bag>
         </pdfx:AuthoritativeDomain>
         <pdfx:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>sciencedirect.com</rdf:li>
               <rdf:li>elsevier.com</rdf:li>
            </rdf:Seq>
         </pdfx:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:jav="http://www.niso.org/schemas/jav/1.0/">
         <jav:journal_article_version>VoR</jav:journal_article_version>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:crossmark="http://crossref.org/crossmark/1.0/">
         <crossmark:CrossmarkDomainExclusive>true</crossmark:CrossmarkDomainExclusive>
         <crossmark:MajorVersionDate>2010-04-23</crossmark:MajorVersionDate>
         <crossmark:DOI>10.1016/j.clml.2023.11.001</crossmark:DOI>
         <crossmark:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>sciencedirect.com</rdf:li>
               <rdf:li>elsevier.com</rdf:li>
            </rdf:Seq>
         </crossmark:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xmpRights="http://ns.adobe.com/xap/1.0/rights/">
         <xmpRights:Marked>True</xmpRights:Marked>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:ali="http://www.niso.org/schemas/ali/1.0/">
         <ali:license_ref>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ali:uri>http://creativecommons.org/licenses/by/4.0/</ali:uri>
               </rdf:li>
            </rdf:Bag>
         </ali:license_ref>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 194
     Sequence: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 460, 716, 541, 727
      Annotation: 
       Subtype: Link
       Rect: 198, 577, 206, 595
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 308, 577, 315, 595
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 413, 577, 420, 595
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 504, 577, 512, 595
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 209, 560, 216, 578
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 333, 560, 341, 578
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 416, 560, 424, 578
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 515, 560, 522, 578
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 149, 543, 157, 561
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 221, 543, 234, 561
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 316, 543, 329, 561
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 430, 543, 443, 561
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 518, 543, 531, 561
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 147, 526, 160, 544
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 248, 526, 261, 544
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 406, 526, 419, 544
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 518, 526, 531, 544
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 216, 509, 229, 527
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 283, 509, 296, 527
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 380, 509, 393, 527
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 479, 509, 492, 527
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 264, 492, 277, 510
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 429, 492, 442, 510
       Destination: 811
      Annotation: 
       Subtype: Link
       Rect: 349, 72, 412, 81
      Annotation: 
       Subtype: Link
       Rect: 425, 37, 539, 47
      Annotation: 
       Subtype: Link
       Rect: 427, 27, 541, 37
    Page: 
     Label: 195
     Sequence: 2
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 319, 627, 496, 638
      Annotation: 
       Subtype: Link
       Rect: 278, 537, 288, 548
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 164, 501, 170, 512
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 170, 501, 175, 512
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 232, 489, 242, 500
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 152, 465, 158, 476
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 158, 465, 163, 476
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 250, 453, 258, 465
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 103, 405, 111, 417
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 120, 369, 129, 381
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 114, 286, 123, 297
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 130, 238, 138, 249
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 138, 238, 147, 249
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 81, 178, 90, 190
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 207, 142, 215, 154
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 254, 118, 263, 130
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 358, 549, 367, 560
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 511, 477, 520, 488
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 337, 226, 345, 237
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 400, 202, 409, 213
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 472, 142, 488, 154
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 364, 71, 373, 82
       Destination: 112
    Page: 
     Label: 196
     Sequence: 3
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 252, 617, 261, 629
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 261, 617, 269, 629
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 74, 211, 82, 222
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 82, 211, 91, 222
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 228, 211, 236, 222
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 508, 701, 536, 713
       Destination: 48
      Annotation: 
       Subtype: Link
       Rect: 334, 642, 362, 653
       Destination: 48
      Annotation: 
       Subtype: Link
       Rect: 359, 437, 390, 449
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 453, 413, 483, 425
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 471, 390, 501, 401
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 369, 366, 400, 377
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 499, 354, 531, 365
       Destination: 64
    Page: 
     Label: 197
     Sequence: 4
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 79, 546, 84, 557
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 94, 507, 99, 518
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 93, 494, 97, 505
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 94, 481, 99, 492
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 93, 468, 97, 479
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 160, 442, 165, 453
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 140, 235, 145, 246
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 250, 70, 283, 82
       Destination: 72
      Annotation: 
       Subtype: Link
       Rect: 479, 71, 511, 83
       Destination: 72
    Page: 
     Label: 198
     Sequence: 5
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 217, 200, 248, 211
       Destination: 72
      Annotation: 
       Subtype: Link
       Rect: 209, 164, 240, 175
       Destination: 72
    Page: 
     Label: 199
     Sequence: 6
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 198, 287, 215, 299
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 340, 276, 349, 287
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 349, 276, 357, 287
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 514, 216, 523, 228
       Destination: 112
      Annotation: 
       Subtype: Link
       Rect: 495, 192, 503, 204
       Destination: 112
    Page: 
     Label: 200
     Sequence: 7
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 130, 654, 138, 665
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 305, 367, 562, 390
      Annotation: 
       Subtype: Link
       Rect: 387, 344, 459, 351
    Page: 
     Label: 201
     Sequence: 8
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 401, 492, 502, 499
      Annotation: 
       Subtype: Link
       Rect: 315, 441, 560, 468
      Annotation: 
       Subtype: Link
       Rect: 315, 417, 560, 444
      Annotation: 
       Subtype: Link
       Rect: 315, 385, 560, 420
      Annotation: 
       Subtype: Link
       Rect: 315, 361, 560, 389
      Annotation: 
       Subtype: Link
       Rect: 315, 337, 560, 365
      Annotation: 
       Subtype: Link
       Rect: 315, 313, 560, 341
      Annotation: 
       Subtype: Link
       Rect: 315, 289, 560, 317
      Annotation: 
       Subtype: Link
       Rect: 315, 266, 560, 293
      Annotation: 
       Subtype: Link
       Rect: 315, 242, 560, 269
      Annotation: 
       Subtype: Link
       Rect: 315, 218, 560, 245
      Annotation: 
       Subtype: Link
       Rect: 315, 194, 560, 221
      Annotation: 
       Subtype: Link
       Rect: 315, 162, 560, 197
      Annotation: 
       Subtype: Link
       Rect: 315, 138, 560, 165
      Annotation: 
       Subtype: Link
       Rect: 315, 106, 560, 142
      Annotation: 
       Subtype: Link
       Rect: 315, 90, 560, 110
      Annotation: 
       Subtype: Link
       Rect: 315, 67, 560, 87
    Page: 
     Label: 202
     Sequence: 9
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 67, 720, 283, 728
      Annotation: 
       Subtype: Link
       Rect: 44, 686, 295, 714
      Annotation: 
       Subtype: Link
       Rect: 44, 662, 295, 690
      Annotation: 
       Subtype: Link
       Rect: 44, 639, 295, 666
      Annotation: 
       Subtype: Link
       Rect: 44, 615, 295, 642
      Annotation: 
       Subtype: Link
       Rect: 44, 583, 295, 618
      Annotation: 
       Subtype: Link
       Rect: 44, 551, 295, 586
      Annotation: 
       Subtype: Link
       Rect: 44, 527, 295, 554
      Annotation: 
       Subtype: Link
       Rect: 44, 503, 295, 530
      Annotation: 
       Subtype: Link
       Rect: 44, 471, 295, 507
      Annotation: 
       Subtype: Link
       Rect: 317, 718, 562, 738
      Annotation: 
       Subtype: Link
       Rect: 317, 702, 562, 722
      Annotation: 
       Subtype: Link
       Rect: 317, 678, 562, 706
      Annotation: 
       Subtype: Link
       Rect: 317, 654, 562, 682
      Annotation: 
       Subtype: Link
       Rect: 317, 623, 562, 658
      Annotation: 
       Subtype: Link
       Rect: 317, 591, 562, 626
      Annotation: 
       Subtype: Link
       Rect: 317, 567, 562, 594
      Annotation: 
       Subtype: Link
       Rect: 317, 535, 562, 570
      Annotation: 
       Subtype: Link
       Rect: 317, 511, 562, 538
  Checksum: a99e7fec
   Type: CRC32
  Checksum: 2d6e238ddde8247d8aa749467999543a
   Type: MD5
  Checksum: b74b1ab0486f833ffa2189898bce9a884ff38c87
   Type: SHA-1
  Checksum: 8cce80d2e48467cf648d57c534b4c08520958fd458b3ded7368df18a73ca8434
   Type: SHA-256